Qube Research & Technologies (QRT)’s Frontline FRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$27.1M Buy
777,142
+649,967
+511% +$19.9M 0.03% 703
2025
Q4
$2.77M Buy
+127,175
New +$2.97M ﹤0.01% 2100
2024
Q3
Sell
-52,657
Closed -$1.36M 3574
2024
Q2
$1.36M Buy
+52,657
New +$1.34M ﹤0.01% 1773
2024
Q1
Sell
-614,337
Closed -$12.3M 4604
2023
Q4
$12.3M Buy
614,337
+505,723
+466% +$10.5M 0.02% 662
2023
Q3
$2.04M Sell
108,614
-647,859
-86% -$10.9M 0.01% 1373
2023
Q2
$11M Buy
+756,473
New +$11.3M 0.04% 514
2022
Q2
Sell
-10,561
Closed -$93K 2703
2022
Q1
$93K Buy
+10,561
New +$83.6K ﹤0.01% 2085

Other funds holding FRO

Qube Research & Technologies (QRT)'s FRO Position: Q1 2026 in Review

Qube Research & Technologies (QRT) increased its Frontline (FRO) stake by 511% in Q1 2026, buying an estimated $19.9M and bringing the position to 777,142 shares worth $27.1M. The position accounts for 0.03% of the portfolio, ranked #703.

Qube Research & Technologies (QRT) first reported a position in FRO in Q1 2022 and has held it in 7 quarters since. 239 funds tracked by Wall St. Rank hold FRO as of Q1 2026.

  • Qube Research & Technologies (QRT) held 777,142 shares of Frontline worth $27.1M as of Q1 2026.
  • Qube Research & Technologies (QRT) bought 649,967 Frontline shares in Q1 2026, an estimated $19.9M.
  • Frontline made up 0.03% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #703 holding.
  • Qube Research & Technologies (QRT) first reported a position in Frontline in Q1 2022 and has held it in 7 quarters since.
  • 239 funds tracked by Wall St. Rank held Frontline as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.